Dual Specificity Antibody Fusions - EP2535350

The patent EP2535350 was granted to UCB Biopharma Sprl on Jan 24, 2018. The application was originally filed on Sep 26, 2008 under application number EP12183573A. The patent is currently recorded with a legal status of "No Opposition Filed Within Time Limit".

EP2535350

UCB BIOPHARMA SPRL
Application Number
EP12183573A
Filing Date
Sep 26, 2008
Status
No Opposition Filed Within Time Limit
Nov 30, 2018
Grant Date
Jan 24, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents